Skip to search formSkip to main contentSkip to account menu

Angiozyme

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Catalytic RNAanti-FLT-1 ribozyme

Narrower (1)

Ribozyme RPI.4610

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors
Purpose: This study intended to determine the maximum tolerated dose, safety, pharmacokinetic variables, clinical response, and… 
2000
2000
Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkey.
The potential acute toxicity of a ribozyme (ANGIOZYME) targeting the flt-1 vascular endothelial growth factor (VEGF) receptor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)